Navigation Links
GeneLink Announces HelixLife Private Label Distribution Agreement
Date:9/24/2010

ORLANDO, Fla., Sept. 24 /PRNewswire/ -- GeneLink BioSciences, Inc. (OTC Bulletin Board: GNLK, www.genelinkbio.com) today announced the launch of HelixLife, (www.helixlife.com), a private label distribution partnership serving the healthcare and wellness industries.

Gary Beeman, GeneLink CEO, stated, "HelixLife gives GeneLink reach into new areas of the rapidly expanding personalized wellness markets that previously have not been available to us.  The HelixLife team is very experienced and will expand the visibility and healthcare market penetration of our 'Powered by GeneLink' technologies and our unique genetically-guided nutritional and skin care products."  

Brad Rex, HelixLife CEO added, "We are excited to showcase GeneLink's 16 years of incredible DNA research and product development with the HelixLife product line of anti-aging nutritional supplements and skin serums, youth supplements and anti-acne products.  We look forward to working together to optimize our customer's health, appearance and well being."

The HelixLife product line includes:  

HelixLife brilliant™ custom DNA nutritional adult supplements and anti-aging skin serum formulated and manufactured to each customer's specific genetic profile,

HelixLife assess™ DNA nutritional and skin assessment test,

HelixLife bright™ full-spectrum adult foundational supplements,

HelixLife grow™ nutritional supplements custom-designed for youth ages 11-17,

HelixLife glow™ natural and organic anti-aging skin serum,

HelixLife clear™ non-chemical based anti-acne skin serum, and

HelixLife active™ chocolate-based energy chews, a healthy alternative to energy drinks

HelixLife products are manufactured in the USA from the highest quality, freshest ingredients, and are shipped directly from production to customer, not warehouse-stored.  For more information, go to www.helixlife.com.

About GeneLink BioSciences, Inc.  

GeneLink is a genomics, biotechnology, and wellness company engaged in genetic test development, product development, and manufacturing of personalized wellness products.  GeneLink's patented and proprietary technologies include genetic assessments focused on the delivery of personally customized and manufactured nutritional supplements and skin care products for health, beauty and wellness applications. For additional information, please visit www.genelinkbio.com.

This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.



'/>"/>
SOURCE GeneLink BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeneLink Reports First Quarter Gains
2. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
3. SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings
4. PAREXEL Announces Date of First Quarter Fiscal Year 2011 Earnings Release and Conference Call
5. Advanced Targeting Systems, Inc. Announces $3 Million Award from National Cancer Institute
6. Genesis Biopharma Announces $700K Private Financing
7. S*BIO Announces US$5 Million Investment by Mitsui Ventures
8. Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
9. TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
10. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
11. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... ... January 13, 2017 , ... ... to offer its customers three new solutions for measurements where traditional cuvette applications ... if a customer has an oddly-shaped sample that would not fit into a ...
(Date:1/12/2017)... ... ... Huffman Engineering, Inc. , a leader in control systems integration, today ... office as a chemical engineer. In his new role, Beck will use his ... science manufacturing and water/wastewater industries. , Prior to joining Huffman Engineering, Beck served for ...
(Date:1/12/2017)... 2017 A new report published by Allied Market Research titled, ... Analysis and Industry Forecast, 2014-2022," projects that the global in vitro toxicity testing market ... CAGR of 15.07% during the forecast period. Continue Reading ... ... ...
(Date:1/11/2017)... ... January 11, 2017 , ... Ovation Fertility™ Genetics ... reliable preimplantation genetic screening (PGS). , “Our genetics and IVF teams are recognized ... Genetics Scientific Director Amy Jones, M.S., ELD (ABB) , who has worked ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec 16, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... The biometric ... grow at a CAGR of 14.06% from 2016 to 2021. The ... is projected to reach 854.8 Million by 2021. The growth of ...
(Date:12/15/2016)... , Dec 15, 2016 ... Research and Markets has announced the ... their offering. The report forecasts the global military biometrics ... The report has been prepared based on an in-depth ... landscape and its growth prospects over the coming years. The report also ...
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):